The Pharmaceutical Journal
Vol 275 No 7367 p330
17 September 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Investing saves money

Increased prescribing of statins and more intensive management of diabetes could save the NHS in Scotland money in the long term, according to a report published this week.

“The future burden of CHD and diabetes in Scotland: the value of healthcare innovation” was commissioned by the Association of the British Pharmaceutical Industry and produced by economic consultancy group NERA.